Tempus AI’s diagnostic platform drives growth, but US healthcare reimbursement remains a hurdle. Learn why TEM stock is worth watching before buying.

Shares of Tempus AI climbed more than 5% on Thursday afternoon, poised for their longest winning streak since August 2024. The healthcare technology company has surged from $35 to $53 in just three ...

In fact, the film’s Oscar chances are currently up in the air, thanks to a recent controversy surrounding The Brutalist’s use of Artificial Intelligence. Don’t get the big deal? Here’s what you need ...

In a move that highlights Saudi Arabia’s ongoing efforts to strengthen its economic ties with the United States, Crown Prince Mohammed bin Salman (MBS) announced a significant pledge to President ...

Tempus AI announces the launch of olivia, an AI-enabled personal health concierge app designed to revolutionize patient care ...

Shares of Tempus AI (TEM) are down 92c, or 2%, to $49.53 in Thursday morning trading after it was disclosed in a regulatory filing last night ...

Tempus AI claims to have a one-stop-shop, with a flywheel platform that becomes better with each new client. See why I rate ...

Tempus AI’s olivia app allows patients to consolidate healthcare data onto a single platform and gain insights using AI.